Anti-Albuminuric Effects of the Angiotensin AT1 Receptor Blocker Telmisartan in Hypertensive Patients

• Published in: Clinical and experimental hypertension (1993) Vol. 33; no. 8; pp. 506 - 510
• Main Authors: Rodríguez-Pérez, José C., García-Bello, Miguel A., Anabitarte-Prieto, Aránzazu, Companioni, Osmel, Nóvoa-Mogollón, Francisco J., Suárez-Ortega, Saturnino, Plaza-Toledano, Celia, Rodríguez-Esparragón, Francisco
• Format: Journal Article
• Language: English
• Published: England Informa Healthcare 01.12.2011; Taylor & Francis
• Subjects: Adult; Aged; Aged, 80 and over; albuminuria; Albuminuria - drug therapy; Amlodipine - administration & dosage; Angiotensin II Type 1 Receptor Blockers - administration & dosage; Antihypertensive Agents - administration & dosage; Benzimidazoles - administration & dosage; Benzoates - administration & dosage; Blood Pressure - drug effects; Creatinine - blood; diabetes mellitus; Diabetic Nephropathies - drug therapy; Drug Therapy, Combination; Female; Glomerular Filtration Rate - drug effects; Humans; hypertension; Hypertension, Renal - drug therapy; Male; Middle Aged; Prospective Studies; renoprotection; Sulfonamides - administration & dosage; telmisartan; Treatment Outcome

We evaluated the anti-hypertensive and anti-albuminuric effect of the angiotensin receptor blocker telmisartan alone and in combination with torasemide and amlodipine. Patients were hypertensive, both diabetics and non-diabetics with persistent microalbuminuria. Our primary endpoint was a change in...